获取途径

作者

Zhao, Lei

作者单位

Department of Hepatobiliopancreatic Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University, Jinan, 250117, China

刊名

Chinese Journal of Clinical Oncology

年份

2020

卷号

Vol.47 No.11

页码

552

ISSN

1000-8179

摘要

The incidence of colorectal cancer is increasing rapidly in China. In fact, in 2019, China was the country with the highest CRC case numbers in the world. Specific myeloid cell subsets are recruited into the liver micro-environment via chemokine-receptor axis and facilitate the progression of colorectal liver metastasis. In China, many CRC patients suffer concomitant chronic liver diseases, such as chronic hepatitis B , nonalcoholic fatty liver disease , and alcoholic liver disease . Aberrant e...更多

The incidence of colorectal cancer is increasing rapidly in China. In fact, in 2019, China was the country with the highest CRC case numbers in the world. Specific myeloid cell subsets are recruited into the liver micro-environment via chemokine-receptor axis and facilitate the progression of colorectal liver metastasis. In China, many CRC patients suffer concomitant chronic liver diseases, such as chronic hepatitis B , nonalcoholic fatty liver disease , and alcoholic liver disease . Aberrant expression of chemokines is observed in these chronic liver diseases, and some of them have been associated with cancer metastasis. Here, first, we review the recent epidemiological trends of CRC, CHB, NAFLD, and ALD in China, briefly summarizing the abnormal chemokine changes in these chronic liver diseases. Furthermore, we review the potential mechanisms that may explain how different chronic liver diseases facilitate CRLM, focusing on the chemokine-myeloid cell subsets axis, which has been previously reported to be related to CRLM.收起

文献类型

期刊

浏览量

18